BIOMAT Database Logo BIOMAT Database Logo

Concentration of progenitor cells collected from bone marrow fluid using a continuous flow cell separator. 2001

K Tsubaki, and T Ariyama, and T Ueno, and Y Kogi, and S Itoh, and Y Kanemitsu, and T Ashida, and A Kanamaru
Department of Internal Medicine, Nara Hospital, Kinki University School of Medicine, Ikoma-city, Japan.

In ABO major incompatibility on bone marrow transplantation (BMT), red cells must be removed from collected marrow fluid to prevent hemolysis. We report the concentration of progenitor cells collected using a continuous flow cell separator (Cobe Spectra). The average volume of concentrated bone marrow was 132 +/- 47 ml and that of red cells included was 5.1 +/- 2.4 ml. The red cell removal rate was 97.6%. The recovery rate was 40.6% for total nuclear cells, 77.9% for mononuclear cells, 100% for CD34+ cells, and 93.9% for colony forming unit granulocyte-macrophage. Eighteen patients undergoing allogeneic BMT showed no signs of fever or hemolysis during concentrated marrow fluid transfusion. The recovery rate of progenitor cells was high, indicating sufficient recovery of hemopoiesis. This technique is applicable in ABO-incompatible BMT and in frozen-storage stem cells.

UI MeSH Term Description Entries
D001772 Blood Cell Count The number of LEUKOCYTES and ERYTHROCYTES per unit volume in a sample of venous BLOOD. A complete blood count (CBC) also includes measurement of the HEMOGLOBIN; HEMATOCRIT; and ERYTHROCYTE INDICES. Blood Cell Number,Blood Count, Complete,Blood Cell Counts,Blood Cell Numbers,Blood Counts, Complete,Complete Blood Count,Complete Blood Counts,Count, Blood Cell,Count, Complete Blood,Counts, Blood Cell,Counts, Complete Blood,Number, Blood Cell,Numbers, Blood Cell
D001787 Blood Group Incompatibility An antigenic mismatch between donor and recipient blood. Antibodies present in the recipient's serum may be directed against antigens in the donor product. Such a mismatch may result in a transfusion reaction in which, for example, donor blood is hemolyzed. (From Saunders Dictionary & Encyclopedia of Laboratory Medicine and Technology, 1984). ABO Compatibility,ABO Incompatibility,Blood Group ABO Incompatibility,Blood Type Incompatibility,Rh Compatibility,Rh Incompatibility,ABO Compatibilities,ABO Incompatibilities,Blood Group Incompatibilities,Blood Type Incompatibilities,Compatibility, ABO,Compatibility, Rh,Incompatibilities, Blood Group,Incompatibility, ABO,Incompatibility, Blood Group,Incompatibility, Blood Type,Incompatibility, Rh,Rh Compatibilities,Rh Incompatibilities
D005434 Flow Cytometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000017 ABO Blood-Group System The major human blood type system which depends on the presence or absence of two antigens A and B. Type O occurs when neither A nor B is present and AB when both are present. A and B are genetic factors that determine the presence of enzymes for the synthesis of certain glycoproteins mainly in the red cell membrane. ABH Blood Group,ABO Blood Group,ABO Factors,Blood Group H Type 1 Antigen,H Blood Group,H Blood Group System,ABO Blood Group System,Blood Group, ABH,Blood Group, ABO,Blood Group, H,Blood-Group System, ABO,Factors, ABO,System, ABO Blood-Group
D016465 Bone Marrow Purging Techniques for the removal of subpopulations of cells (usually residual tumor cells) from the bone marrow ex vivo before it is infused. The purging is achieved by a variety of agents including pharmacologic agents, biophysical agents (laser photoirradiation or radioisotopes) and immunologic agents. Bone marrow purging is used in both autologous and allogeneic BONE MARROW TRANSPLANTATION. Hematopoietic Stem Cell Purging,Purging, Bone Marrow
D018380 Hematopoietic Stem Cell Transplantation Transfer of HEMATOPOIETIC STEM CELLS from BONE MARROW or BLOOD between individuals within the same species (TRANSPLANTATION, HOMOLOGOUS) or transfer within the same individual (TRANSPLANTATION, AUTOLOGOUS). Hematopoietic stem cell transplantation has been used as an alternative to BONE MARROW TRANSPLANTATION in the treatment of a variety of neoplasms. Stem Cell Transplantation, Hematopoietic,Transplantation, Hematopoietic Stem Cell
D019337 Hematologic Neoplasms Neoplasms located in the blood and blood-forming tissue (the bone marrow and lymphatic tissue). The commonest forms are the various types of LEUKEMIA, of LYMPHOMA, and of the progressive, life-threatening forms of the MYELODYSPLASTIC SYNDROMES. Blood Cancer,Hematologic Malignancies,Hematopoietic Neoplasms,Hematologic Malignancy,Hematological Malignancies,Hematological Neoplasms,Hematopoietic Malignancies,Malignancies, Hematologic,Malignancy, Hematologic,Neoplasms, Hematologic,Neoplasms, Hematopoietic,Blood Cancers,Cancer, Blood,Hematologic Neoplasm,Hematological Malignancy,Hematological Neoplasm,Hematopoietic Malignancy,Hematopoietic Neoplasm,Malignancy, Hematological,Malignancy, Hematopoietic,Neoplasm, Hematologic,Neoplasm, Hematological,Neoplasm, Hematopoietic

Related Publications

K Tsubaki, and T Ariyama, and T Ueno, and Y Kogi, and S Itoh, and Y Kanemitsu, and T Ashida, and A Kanamaru
Continuous flow cell separator use for bone marrow processing.
January 1991, Transfusion science,
K Tsubaki, and T Ariyama, and T Ueno, and Y Kogi, and S Itoh, and Y Kanemitsu, and T Ashida, and A Kanamaru
Concentration of bone marrow mononuclear cells using a programmable blood cell separator.
January 1991, Journal of clinical apheresis,
K Tsubaki, and T Ariyama, and T Ueno, and Y Kogi, and S Itoh, and Y Kanemitsu, and T Ashida, and A Kanamaru
Concentration of hematopoietic progenitor cells from human bone marrow by a new type of blood component separator.
January 1985, Vox sanguinis,
K Tsubaki, and T Ariyama, and T Ueno, and Y Kogi, and S Itoh, and Y Kanemitsu, and T Ashida, and A Kanamaru
Plasmapheresis using the continuous flow cell separator.
August 1983, The Australian nurses' journal. Royal Australian Nursing Federation,
K Tsubaki, and T Ariyama, and T Ueno, and Y Kogi, and S Itoh, and Y Kanemitsu, and T Ashida, and A Kanamaru
Automated bone marrow concentration using the Fresenius AS 104 blood cell separator.
January 1994, Beitrage zur Infusionstherapie und Transfusionsmedizin = Contributions to infusion therapy and transfusion medicine,
K Tsubaki, and T Ariyama, and T Ueno, and Y Kogi, and S Itoh, and Y Kanemitsu, and T Ashida, and A Kanamaru
Effective concentration of bone marrow mononuclear cells using density gradient separation within an automated cell separator.
July 1992, Transfusion science,
K Tsubaki, and T Ariyama, and T Ueno, and Y Kogi, and S Itoh, and Y Kanemitsu, and T Ashida, and A Kanamaru
The continuous flow cell separator.
November 1978, Nursing times,
K Tsubaki, and T Ariyama, and T Ueno, and Y Kogi, and S Itoh, and Y Kanemitsu, and T Ashida, and A Kanamaru
Enrichment of progenitor cells from human bone marrow by flow cytometry.
December 1988, Molecular and cellular biochemistry,
K Tsubaki, and T Ariyama, and T Ueno, and Y Kogi, and S Itoh, and Y Kanemitsu, and T Ashida, and A Kanamaru
Separation of mononuclear bone marrow cells using the Cobe 2997 blood cell separator.
January 1988, Vox sanguinis,
K Tsubaki, and T Ariyama, and T Ueno, and Y Kogi, and S Itoh, and Y Kanemitsu, and T Ashida, and A Kanamaru
Isolation of Dendritic Cell Progenitor and Bone Marrow Progenitor Cells from Mouse.
January 2016, Methods in molecular biology (Clifton, N.J.),
Copied contents to your clipboard!